In the space of a week, Amazon has launched an online pharmacy pilot in India, the country's largest retailer has retaliated by buying a controlling stake in established rival Netmeds, and the market's other two largest players - PharmEasy and Medlife - have merged to create a $1.2bn+ valued company. This is despite ongoing legislation that might ban e-pharmacies from any activity at all.